Dr Aditi Bhatt
MBBS, MS (General Surgery), MCh. (Surgical Oncology)
Dr Aditi Bhatt is a specialist in the management of peritoneal surface malignancies. She has been performing CRS and HIPEC for appendiceal tumours, pseudomyxoma peritonei, ovarian cancer, colorectal cancer, peritoneal mesothelioma and other peritoneal malignancies for the last 10 years. PIPAC and other palliative treatments for peritoneal malignancies are also available at her centre.
Her key areas of research are surgical therapies for ovarian cancer, outcomes of surgical treatment of peritoneal metastases in the Indian subcontinent and patterns of peritoneal dissemination in various primary and secondary peritoneal malignancies. She is a founding member and the secretary of the Society of Peritoneal Surface Oncology, India (SPSOI) and a member of the executive committee of the Peritoneal Surface Oncology Group International (PSOGI). She has published nearly 75 research papers and edited two books on peritoneal surface malignancies.
Department of surgical oncology,
Zydus Hospital,
Zydus hospital road,
Thaltej,
Ahmedabad 380054,
India
t: 91 9686447863, 91 79 6619 0200, 91 79 6619 0201
e: [email protected], [email protected]
w: www.draditibhatt.com, www.zydushospitals.com
Our medical advisors
Mr Faheez Mohamed
Faheez Mohamed is a consultant colorectal surgeon at The Peritoneal Malignancy Institute in Basingstoke, UK.
Professor Norman Carr
Norman John Carr was previously Director of Research and Consultant Histopathologist at the Peritoneal Malignancy Institute, Basingstoke
Prof Wim P Ceelen
Prof Wim Ceelen is a senior GI surgeon at Ghent University Hospital, also an Associate Professor in surgical oncology at Ghent University.
Laura Lambert MD
Laura Lambert, MD is a surgical oncologist who specializes in treating peritoneal surface malignancies including pseudomyxoma peritonei.
Professor Paul Moroz
Prof. Moroz advises Pseudomyxoma Survivor, as a specialist in pseudomyxoma peritonei and HIPEC treatment, based in Australia.
Dr Jason Spendelow
Supporting our commitment to living with pseudomyxoma peritonei and appendix cancer, we welcome Dr Spendelow as a medical advisor.